Trial Profile
Clinical Trials Insight: 700022183
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Apr 2007
Price :
$35
*
At a glance
- Drugs 4-demethylpenclomedine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Xanthus Pharmaceuticals
- 03 Apr 2007 New trial record.